Specimen SS-F-UMA-298 // UMAMI · IFI-U
Nucleotide Synergy III-AG-B
Glycine max
Soybean
Target Trait
4.31×
fold-change
IMP + GMP combined nucleotide synergy score
Technical Specifications
SKU
SS-F-UMA-298
Genomic Edits
9
GC Content
48.2-54.2%
Construct Length
4,779 bp
Promoter System
Tissue-specific 2A11 / CaMV35S
Expression System
Agrobacterium-mediated T-DNA
Host Strain
EHA105
Receptor Target
mGluR1 / TAS1R1-TAS1R3
IFI Score
431
Pathway Edits
- GmADSS adenylosuccinate synthase overexpression for elevated IMP via de-novo purine pathway in Glycine max seed tissue
- GmIMPDH2 inosine monophosphate dehydrogenase balanced overexpression for IMP/GMP co-accumulation without net IMP depletion
- GmGMPS GMP synthase activity tuned to 60% of IMPDH output to maintain 1.7:1 IMP:GMP ratio for maximum synergy
- GmADSL adenylosuccinate lyase upregulation ensuring AMP/IMP cycling prevents adenylate deficiency during IMP accumulation phase
- GmNT5C 5′-nucleotidase expression calibrated via synthetic promoter strength to maintain free nucleotide fraction over phosphorylated forms
- GmPNP purine nucleoside phosphorylase isoform 2 overexpression for nucleoside salvage amplification across IMP and GMP branches
- GmGDH glutamate dehydrogenase upregulation for co-production of free glutamate to enhance nucleotide synergy via triple co-agonism
- GmAMPD AMP deaminase partial knockdown (40%) to prevent IMP loss via adenylate catabolism during seed maturation
- GmUMPS UMP synthase redirection variant for pyrimidine overflow suppression, maintaining carbon flux in purine pathway
Key Interventions
IFI Subscale Profile
IFI Profile
Use Case
Soy-based umami concentrates, plant-based meat flavor systems, and fermented tofu products where dual-nucleotide synergy delivers maximum umami without exogenous additives. Ideal for functional food ingredient manufacturers.
License
$1549 · Tier III License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?